Viewing nowApeco Tablet 10 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 10.845mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

MFDS item code 201300149 · Approved 2013.01.08 · Insurance code 643703590
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular diseases (including myocardial infarction)
This medication helps to reduce various risk factors associated with cardiovascular disease. In particular, it reduces the risk of myocardial infarction and stroke in adults with multiple risk factors and patients with type 2 diabetes. Additionally, it is effective in reducing the risk of non-fatal myocardial infarction, stroke, vascular interventions, and hospitalization for heart failure in patients with clinical evidence of heart disease. In hyperlipidemia patients, it lowers total cholesterol, LDL cholesterol, and triglyceride levels while raising HDL cholesterol levels, thereby supporting dietary therapy. It is particularly helpful in managing cholesterol levels effectively in patients with familial hypercholesterolemia and in pediatric patients. This medication is used for the reduction of cardiovascular disease risk and the improvement of dyslipidemia.
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when starting treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients 70 years of age or older are generally similar to those in the usual adult patient population.
10 ~ 17 years: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients).
This medication may cause unusual symptoms in muscles, so if severe muscle pain or muscle weakness occurs, or if creatine kinase levels rise significantly, discontinue use immediately and consult a physician. Patients with liver function issues or active liver disease should not use this medication. Patients with muscle disorders or those who have previously experienced muscle-related side effects should use this medication cautiously and may require regular testing. Women who are pregnant, potentially pregnant, or nursing should not take this medication, and women of childbearing age should use adequate contraception while taking this medication. This medication may interact with certain antibiotics, antifungals, and antivirals, so if taking other medications, be sure to inform your doctor or pharmacist. Elderly patients or those with impaired kidney function are at increased risk for muscle-related side effects, so caution is needed when taking this medication. During treatment with this medication, regular liver function tests and muscle-related tests should be conducted, and it is important to inform healthcare providers of any adverse symptoms. Children, especially those under 10 years of age, should not use this medication, and for children over 10, long-term safety has not been adequately verified. There is no specific antidote for overdose, and treatment should be based on symptoms, requiring regular testing. This medication should be kept out of reach of children and should be stored in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to safely preserve its efficacy.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.845mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.